所属 |
附属病院 歯科口腔外科 |
研究等業績 【 表示 / 非表示 】
-
上顎切除後にミリングバーを応用した広範囲顎骨支持型補綴にて咬合再建を行った3例
福地 峰世, 高野 裕史, 山崎 雅人, 有馬 実咲, 伊東 慶介, 鈴木 兼一郎, 今野 泰典, 五十嵐 秀光, 福田 雅幸
Japanese Journal of Maxillo Facial Implants 2022年08月 [査読有り]
研究論文(学術雑誌) 国内共著
-
Neutrophil and eosinophil ETosis-mediated extracellular trap formation in a patient with chronic granulomatous disease
Miyabe Yui, Yano Michihiro, Fukuchi Mineyo, Watanabe Ken, Moritoki Yuki, Saga Tomoo, Takahashi Tsutomu, Ueki Shigeharu
Allergology International 2022年08月 [査読有り]
研究論文(学術雑誌) 国内共著
-
Fibrous dysplasia of the zygomatic bone and mandibular coronoid process: A case report
Fukuchi M.
Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology ( Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology ) 35 ( 6 ) 523 - 527 2023年11月
-
Miyabe Y.
Allergology International ( Allergology International ) 72 ( 1 ) 176 - 178 2023年01月
-
鈴木 兼一郎, 髙野 裕史, 福地 峰世, 五十嵐 秀光, 今野 泰典, 福田 雅幸
日本口腔科学会雑誌 ( 特定非営利活動法人 日本口腔科学会 ) 72 ( 1 ) 20 - 25 2023年
Nivolumab is an anti-PD-1 antibody that is an immune checkpoint inhibitor that blocks PD-1/PD-L1 signals and exerts an antitumor effect. Immune checkpoint inhibitors including nivolumab are known to cause various immune-related adverse events including skin disorders. We report a case of erythema multiforme major (EM major) after nivolumab administration.
<br>A 66-year-old female with mandibular gingival cancer (cT4aN2cM0) underwent bilateral neck dissection and mandibular segmental resection in January 2019. After postoperative concurrent chemoradiation (cisplatin + radiation), multiple lung metastases were diagnosed three months postoperatively, and nivolumab 240mg every two weeks was started. Pruritus of the eyes, erythema of the trunk and extremities, and erosion of the oral mucosa occurred after seven doses of nivolumab had been administered. She was referred to a dermatologist and was admitted to the hospital because of suspicion of Stevens–Johnson syndrome. The symptoms improved daily with Prednisolone administration, and she was discharged from the hospital four weeks later. The final diagnosis was EM major.
<br>Nivolumab is effective for head and neck cancers, but adverse events are more diverse than with conventional chemotherapy. Although most of the skin disorders are reported to be mild, it may be necessary to observe them carefully and be important to treat them in the early stage. -
Galectin-10 as a Potential Biomarker for Eosinophilic Diseases
Tomizawa H.
Biomolecules ( Biomolecules ) 12 ( 10 ) 2022年10月
-
Quantification of Aspergillus fumigatus antigen Asp f 1 in airway tissue and allergic inflammation
Miyabe Y.
Allergy: European Journal of Allergy and Clinical Immunology ( Allergy: European Journal of Allergy and Clinical Immunology ) 77 ( 10 ) 3154 - 3156 2022年10月
◆原著論文【 表示 / 非表示 】
◆その他【 表示 / 非表示 】
学術関係受賞 【 表示 / 非表示 】
-
女性研究者支援コンソーシアムあきた賞
2022年12月 女性研究者支援コンソーシアムあきた 好酸球ETosisによるgalectin-10の放出と新規バイオマーカーの検討
受賞者: 福地 峰世 -
秋田医学会学術奨励賞
2022年02月03日 秋田医学会 好酸球性多発血管炎性肉芽腫症における好酸球ETosisによるgalectin-10の放出
受賞者: 福地 峰世